Korean Market
OWNR
SAMIL PHARMACEUTICAL
★

Samil Pharmaceutical Largest Shareholder CEO Seungbeom Heo Increases Stake from 25.83% to 25.96% via Open Market Purchases and Gift

 
OWNR
SAMIL PHARMACEUTICAL
★

Samil Pharmaceutical Non-Registered Executive Yoo Dam-hyang Increases Stake by 1,000 Shares via On-Market Purchase

 
EXCH
SAMIL PHARMACEUTICAL
★

SAMIL PHARMACEUTICAL Completes 10 Billion KRW Convertible Bond Issuance for Vietnam CMO Investment, Dilution Inevitable

 
OWNR
SAMIL PHARMACEUTICAL
★

Executive Cha Gyeong-yeol Acquires 2,000 Shares of SAMIL PHARMACEUTICAL in Open Market Purchase, Signaling Insider Confidence

 
MATR
SAMIL PHARMACEUTICAL
★

SAMIL PHARMACEUTICAL Decides to Issue 10 Billion Won Convertible Bonds - Funding for Vietnam CMO Factory, Expected 6.07% Share Dilution

 
EXCH
SAMIL PHARMACEUTICAL
★

Samil Pharmaceutical Major Shareholder Ownership Change Report, Minor Increase Neutral to Shareholder Value

 
OWNR
SAMIL PHARMACEUTICAL
★

Samil Pharmaceutical Unregistered Executive Kim Young-dae Acquires 1,000 Shares via Open Market Purchase, Holding 0.01% Stake

 
EXCH
SAMIL PHARMACEUTICAL
★

Samil Pharmaceutical's Largest Shareholder Family Slightly Increases Stake to 25.93% via Open Market Purchase… Controlling Stability Maintained, Minimal Impact on Shareholder Value

 
OWNR
SAMIL PHARMACEUTICAL
★

Samil Pharmaceutical Non-Registered Director Han Byeong-ik Acquires 1,000 Shares via Open Market Purchase…Slight Decrease in Ownership Percentage

 
OWNR
SAMIL PHARMACEUTICAL
★

Samil Pharmaceutical's Non-Registered Executive Yoo Dam-hyang Buys 1,000 Shares at 7,490 KRW, Stake at 0.06%, Limited Shareholder Value Impact

 
EXCH
SAMIL PHARMACEUTICAL
★

SAMIL PHARMACEUTICAL Files Corporate Governance Report... Multiple Areas for Improvement Identified Including Late Shareholder Meeting Notice and No Dividends

 
EXCH
SAMIL PHARMACEUTICAL
★

Heo Yul Acquires 3,020 Shares via Open Market Purchase, Slightly Increasing Majority Stake to 25.90%

 
OWNR
SAMIL PHARMACEUTICAL
★

CEO Heo Seung-beom buys 10,000 shares at 7,922 won via open market purchase

 
EXCH
SAMIL PHARMACEUTICAL
★

Major Shareholder Heo Seung-beom Increases Stake to 25.89% with 10,000 Share Purchase

 
PERI
SAMIL PHARMACEUTICAL
★★★

Samil Pharm: Q1 2026 Consolidated Operating Loss of 8.4B KRW, Continuing Losses and Rising Debt Ratio